CTVACTVABasic Materials · Agricultural Inputs

CTVA Stock Forecast: Corteva, Inc. Price Predictions for 2026-2027

Last close, 21 Aug 2026
$82
+2.93% on the day

The 21 Wall Street analysts covering Corteva, Inc. hold a median 12-month price target of $95 — +16.2% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 63 of 100 as at 22 Aug 2026 — in the upper half.

Market cap
$54.6B
Ticker Nerd rank
63 / 100
Median analyst target
$95
Analysts covering
21
Total return, dividends reinvested
1W
+6.7%
1M
−5.9%
YTD
+22.6%
1Y
+13.2%
From 52W high
−9.6%
From 52W low
+35.1%
$61
$91
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

CTVA stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Corteva, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 22 Aug 2026
63 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Volatility
98
Momentum
75
Quality
70
Value
64
Revisions
60
Issuance
60
Accruals
51
Growth
49
Size
5

Volatility (98): The share price has been relatively steady.

Growth (49): Sales and profits are flat, shrinking, or growing more slowly than they were.

Size (5): Larger than most of the companies we track — more scrutinised, less often mispriced.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

CTVA stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on CTVA, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$60$70$80$90$100$110Oct 25Jan 26Apr 26Jul 26CTVAHigh $103Median $95Low $78

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

What Wall Street says21 analysts
15 Buy6 Hold0 Sell
Low $78Median $95High $103

The green dot is the last close — the median target sits +16.2% from it.

Recent analyst actionsNewest first

Of the 20 most recent actions, 8 moved their price target up and 1 moved it down.

DateFirmActionRatingTarget
18 Aug 2026UBSMaintainsNeutral$89$85
3 Aug 2026BMO CapitalMaintainsOutperform$95$100
3 Aug 2026BMO CapitalMaintainsOutperform
3 Aug 2026CitigroupMaintainsNeutral$85$86
3 Aug 2026CitigroupMaintainsNeutral
3 Aug 2026JP MorganMaintainsNeutral
3 Aug 2026JP MorganMaintainsNeutral$77$83
3 Aug 2026UBSMaintainsNeutral
3 Aug 2026UBSMaintainsNeutral$86$89
23 July 2026OppenheimerMaintainsOutperform$89$95
23 July 2026OppenheimerMaintainsOutperform
21 July 2026RBC CapitalMaintainsOutperform
21 July 2026RBC CapitalMaintainsOutperform$97$103
20 July 2026B of A SecuritiesMaintainsBuy
20 July 2026B of A SecuritiesMaintainsBuy$90$96
14 July 2026MizuhoMaintainsOutperform
14 July 2026MizuhoMaintainsOutperform$96$97
2 July 2026MizuhoMaintainsOutperform
11 June 2026BarclaysMaintainsOverweight
9 June 2026UBSMaintainsNeutral

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. CTVA appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Estimates

CTVA analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
EPS revision, 90 days
+1.0%
Analysts raising
11
Analysts cutting
4
Fundamentals

Corteva, Inc. (CTVA) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
49.6×

Cheaper than 15% of US stocks

Price / sales
3.1×

Cheaper than 41% of US stocks

Price / book
2.2×

Cheaper than 44% of US stocks

EV / EBITDA
13.4×

Cheaper than 28% of US stocks

Growth & margins
Revenue growth (YoY)
−1.2%

Higher than 26% of US stocks

Earnings growth (YoY)
−11.6%

Higher than 25% of US stocks

Gross margin
51.6%

Higher than 64% of US stocks

Operating margin
30.1%

Higher than 87% of US stocks

Net margin
5.7%

Higher than 61% of US stocks

Returns & dividend
Return on equity
4.3%

Higher than 52% of US stocks

Return on assets
4.5%

Higher than 74% of US stocks

Dividend yield
0.9%

Higher than 20% of US dividend payers

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Peers

CTVA vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelAgricultural Inputs
CompanyMarket capTKN rank
CTVACorteva, Inc.$54.6B
63
NTRNutrien Ltd.$35.9B
89
CFCF Industries Holdings, Inc.$20.4B
88
MOSThe Mosaic Co.$7.8B
19
ICLICL Group Ltd.$7.5B
66
SMGScotts Miracle-Gro Co.$3.5B
77
NUENucor Corp.*$55.8B
93

* Nearest Basic Materials names by size — few agricultural inputs companies of this scale trade in the US universe.

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Corteva, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest CTVA news & analysis

Corteva Announces Early Tender Results and Extension of Expiration Date in Private Exchange Offers and Consent Solicitations for EIDP's 2.300% Senior Notes Due 2030, 5.125% Senior Notes Due 2032 and 4.800% Senior Notes Due 2033

PRNewsWire · 20 Aug 2026neutral

Corteva announced that its wholly owned subsidiary Vylor Inc. has received early tender results for exchange offers and consent solicitations involving EIDP's senior notes due 2030, 2032 and 2033, and has extended the expiration date. The consent solicitations seek approval of amendments that would remove substantially all restrictive covenants, events of default, and change-of-control repurchase provisions from the governing indentures.

Why it matters — The exchange offers and consent solicitations affect the structure and covenants of outstanding EIDP notes, which are obligations of a Corteva subsidiary, so the outcome may influence Corteva's balance sheet and debt arrangements.

DOLE vs. CTVA: Which Stock Is the Better Value Option?

Zacks Investment Research · 13 Aug 2026neutral

Zacks Investment Research published a comparison of Dole (DOLE) and Corteva, Inc. (CTVA) as potential value investment options within the Agriculture - Operations sector, examining which stock may offer value investors a better opportunity.

Why it matters — A prominent research outlet is evaluating Corteva against a peer in the agriculture sector, which could influence how investors perceive CTVA's value proposition.

Corteva's Higher 2026 Guidance Puts Investor Focus on Growth Drivers

Zacks Investment Research · 12 Aug 2026neutral

Corteva reported a Q2 earnings beat and raised its 2026 outlook, signaling progress on its growth drivers. The item notes that Crop Protection pricing and separation risks remain.

Why it matters — A CTVA watcher would care because the raised 2026 guidance highlights potential growth drivers, while lingering pricing and separation risks could still affect forward performance.

Corteva Growth Improves, But Valuation Limits Upside

Zacks Investment Research · 12 Aug 2026neutral

Zacks Investment Research noted that Corteva's earnings outlook is improving due to Seed growth and productivity gains, but it cautioned that Crop Protection pricing challenges and separation risks remain, with valuation limiting upside.

Why it matters — CTVA watchers would care because the report highlights both the company's operational strengths and the persistent headwinds that could temper future performance.

New Jersey's $2.5 billion 'forever chemicals' settlements with DuPont, 3M, others win court approval

Reuters · 7 Aug 2026neutral

A federal judge approved over $2.5 billion in settlements that New Jersey reached with DuPont, Chemours, Corteva and 3M to resolve claims over pollution attributed to PFAS, known as "forever chemicals."

Why it matters — Corteva is one of the settling parties in these approved agreements, so the ruling finalizes the company's disposition of these PFAS-related claims in New Jersey.

FAQ

Frequently asked questions about CTVA stock

What is the CTVA stock price forecast for 2026-2027?

The 21 Wall Street analysts covering Corteva, Inc. have a median 12-month price target of $95, with estimates ranging from $78 to $103. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is CTVA stock a buy right now?

Of the 21 analysts covering Corteva, Inc., 15 rate it a Buy, 6 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Corteva, Inc. 63 out of 100 across roughly 4,600 US stocks as at 22 Aug 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank CTVA?

As at 22 Aug 2026, Corteva, Inc. ranks 63 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Volatility (98 of 100).

Will CTVA stock go up?

No one can know that. What the data says: the median 12-month target from 21 analysts implies +16.2% from the last close, and Ticker Nerd's factor model ranks Corteva, Inc. 63 out of 100 as at 22 Aug 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the CTVA stock forecast for 2030?

No analyst covering Corteva, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for CTVA are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $78 to $103 over the next 12 months.

How has CTVA stock performed over the past year?

Corteva, Inc. returned +13.2% over the 12 months to 21 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Corteva, Inc. do?

Corteva Inc. is an agricultural inputs company that provides seed and crop protection solutions to farmers and agricultural businesses worldwide.

What is the latest news on CTVA?

The most recent item we track (PRNewsWire, 20 Aug 2026): "Corteva Announces Early Tender Results and Extension of Expiration Date in Private Exchange Offers and Consent Solicitations for EIDP's 2.300% Senior Notes Due 2030, 5.125% Senior Notes Due 2032 and 4.800% Senior Notes Due 2033". Corteva announced that its wholly owned subsidiary Vylor Inc. has received early tender results for exchange offers and consent solicitations involving EIDP's senior notes due 2030, 2032 and 2033, and has extended the expiration date. The consent solicitations seek approval of amendments that would remove substantially all restrictive covenants, events of default, and change-of-control repurchase provisions from the governing indentures.

Company

About Corteva, Inc.

Corteva Inc. is an agricultural inputs company that provides seed and crop protection solutions to farmers and agricultural businesses worldwide. The company focuses on improving crop productivity and protecting yields through a broad portfolio that includes advanced seeds, herbicides, insecticides, fungicides, seed treatments, and nitrogen management products. Its offerings support a range of major crops and are used across row-crop and specialty agriculture markets. Corteva Inc. plays an important role in the global food supply chain by helping growers manage pests, disease, and weed pressure while supporting more efficient farm operations. Headquartered in Indianapolis, Indiana, Corteva Inc. operates as a dedicated agriscience business with products and services tailored to modern agriculture.

CEO Mr. Charles Victor Magro B.Sc. (Chem), MBA · 21,500 employees · United States · https://www.corteva.com